Metabolon Expands Inflammation Portfolio with Targeted Panels for Cannabinoids, Sphingolipids, and Lipid Mediators of Inflammation

Targeted metabolomics panels provide absolute quantitation to further scientific discovery and inflammation research MORRISVILLE, N.C., Jan. 17, 2023 /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic,…